& Calpis grew 2.7% YoY. Total Personal care continued its momentum with 11.5% growth YoY, with 42.8% growth in CLM markets. International business grew 1.5% at constant FX rate, driven by Myanmar growth
Analysis Quarter 1 Ending 31 March 2019 Highlights Q1/2019, the Company and subsidiary’s total net loss equals Baht 803 million, decreased by Baht 1,298 million or 262% comparing with same period of last
, the Company maintained its leadership position with total market share of 30.5%. - Q2’19 Gross margin improved 400 bps YoY to 35.3%, which brought 1H’19 GM to 35.0% (+330 bps YoY). This was mainly
business), i.e., disposing ordinary shares of NU of 30,599,999 shares, equivalent to 90 percent of the total NU shares to Chirasak Chiyachantana Ph.D. Asso.Prof. at an approximate price of Baht 8.3824 per
Director and Manager The Stock Exchange of Thailand The Company would like to report the Company’s operating result for the 1st Quarter ended March 31, 2018 that total revenue was THB8.24 million decreased
understand the Company and its subsidiaries’ 2018 audited financial statements. An Analysis of Performance * Analysis of Income The Company and its subsidiaries recorded the total revenue of 20,171 MTHB of
make further decision. 2. Operating Results (Company and Subsidiaries) Total revenue of the consolidated financial statements for Q3/2019 amounted 72.6 million baht compared to Q3/2018 with total revenue
subsidiary recorded the total revenue of 18,830 MTHB of which 18,605 MTHB earned from sales revenue. The sales revenue decreased by 1,341 MTHB or 6.7% comparing to the year 2018. Such decrement was due to the
Profit 65 74 -12 Total Revenues In the three-month period ended 30 June 2017 and 2016, total revenues of the Company increased from Baht 510 million to Baht 530 million, increased by Baht 20 million or 4
hospital operations for the year 2015 and 2016 were in amounts of Baht 315.21 million and Baht 354.53 million respectively. The proportion of the costs of hospital operations incurred compared to the total